Core Viewpoint - The Chinese vascular stent market is experiencing a decline in imports due to the accelerated replacement by domestic high-end products and the deepening of centralized procurement policies, while exports are growing significantly as domestic technologies mature [1][12]. Industry Overview - Vascular stents are medical devices implanted in blood vessels to treat conditions like stenosis and aneurysms, playing a crucial role in interventional therapy for cardiovascular diseases [2]. - The industry has evolved through four main stages: reliance on imports, the onset of domestic production, rapid development with drug-eluting stents, and a current phase focused on technological innovation [4][5][6]. Current Industry Status - In the first five months of 2025, China imported 914,000 vascular stents, a year-on-year decrease of 38.18%, with an import value of 1.154 billion yuan, down 18.70% [12]. - Exports during the same period reached 288,900 units, a 30.09% increase, with an export value of 243 million yuan, up 24.03% [12]. - The decline in imports is attributed to the rise of domestic products like MicroPort's Firesorb® bioabsorbable stent and the impact of centralized procurement policies [12]. Industry Development Trends 1. **Technological Innovation and Material Upgrades** - The industry is witnessing a shift towards bioabsorbable materials and smart technologies, with products like MicroPort's Firesorb® stent demonstrating significant advancements [22]. - The introduction of nanotechnology in drug-eluting stents enhances precision in drug delivery, improving clinical outcomes [22]. 2. **Growing Market Demand and Structural Optimization** - The burden of cardiovascular diseases is increasing, with 330 million patients in China, driving demand for vascular stents [24]. - The market is diversifying, with a notable rise in demand for peripheral vascular stents due to related health issues [24]. 3. **Policy Drivers and Competitive Landscape Restructuring** - National policies, including centralized procurement, are enhancing the competitiveness of domestic stents [25]. - Local companies like MicroPort and Lepu Medical are gaining market share from foreign brands through technological advancements and cost advantages [25].